TFS HealthScience

TFS HealthScience is an active global Contract Research Organization specializing in full-service clinical trial management and strategic resourcing solutions. The company partners with biotechnology and pharmaceutical firms to advance innovative treatments across multiple therapeutic areas. With nearly 700–800 employees operating in over 40 countries—including the US and Europe—TFS offers expertise in dermatology, internal medicine, neuroscience/CNS disorders, oncology/hematologic malignancies & solid tumors, ophthalmology/retinal disease trials. They are recognized for their scientific expertise and operational excellence in accelerating drug development programs from early-phase through late-stage studies. Recent collaborations include work on antibody-drug conjugates for pancreatic cancer with Oncomatryx and partnerships to accelerate global clinical research innovation.